1. Home
  2. ALZN vs IPDN Comparison

ALZN vs IPDN Comparison

Compare ALZN & IPDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALZN
  • IPDN
  • Stock Information
  • Founded
  • ALZN 2016
  • IPDN 2003
  • Country
  • ALZN United States
  • IPDN United States
  • Employees
  • ALZN N/A
  • IPDN N/A
  • Industry
  • ALZN Medicinal Chemicals and Botanical Products
  • IPDN EDP Services
  • Sector
  • ALZN Health Care
  • IPDN Technology
  • Exchange
  • ALZN Nasdaq
  • IPDN Nasdaq
  • Market Cap
  • ALZN 9.0M
  • IPDN 9.1M
  • IPO Year
  • ALZN 2021
  • IPDN 2013
  • Fundamental
  • Price
  • ALZN $2.32
  • IPDN $1.82
  • Analyst Decision
  • ALZN Strong Buy
  • IPDN
  • Analyst Count
  • ALZN 1
  • IPDN 0
  • Target Price
  • ALZN $42.00
  • IPDN N/A
  • AVG Volume (30 Days)
  • ALZN 100.6K
  • IPDN 611.2K
  • Earning Date
  • ALZN 12-11-2025
  • IPDN 11-14-2025
  • Dividend Yield
  • ALZN N/A
  • IPDN N/A
  • EPS Growth
  • ALZN N/A
  • IPDN N/A
  • EPS
  • ALZN N/A
  • IPDN N/A
  • Revenue
  • ALZN N/A
  • IPDN $6,497,046.00
  • Revenue This Year
  • ALZN N/A
  • IPDN N/A
  • Revenue Next Year
  • ALZN N/A
  • IPDN N/A
  • P/E Ratio
  • ALZN N/A
  • IPDN N/A
  • Revenue Growth
  • ALZN N/A
  • IPDN N/A
  • 52 Week Low
  • ALZN $2.06
  • IPDN $0.97
  • 52 Week High
  • ALZN $12.87
  • IPDN $12.39
  • Technical
  • Relative Strength Index (RSI)
  • ALZN 45.72
  • IPDN 30.76
  • Support Level
  • ALZN $2.21
  • IPDN $1.79
  • Resistance Level
  • ALZN $2.61
  • IPDN $2.55
  • Average True Range (ATR)
  • ALZN 0.16
  • IPDN 0.25
  • MACD
  • ALZN -0.01
  • IPDN -0.07
  • Stochastic Oscillator
  • ALZN 32.29
  • IPDN 5.41

About ALZN Alzamend Neuro Inc.

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.

About IPDN Professional Diversity Network Inc.

Professional Diversity Network Inc is engaged in providing access to networking, training, educational and employment services to its registered users. It has three operating segments: the TalentAlly Network segment, which maintains and operates job board software and hosts career fairs; the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization; the RemoteMore segment; and Corporate Overhead. The company generates majority of its revenue from TalentAlly Network Segment.

Share on Social Networks: